共 20 条
Comparison of human COP9 signalosome and 26S proteasome 'lid'
被引:71
作者:
Henke, W
Ferrell, K
Bech-Otschir, D
Seeger, M
Schade, R
Jungblut, P
Naumann, M
Dubiel, W
[1
]
机构:
[1] Humboldt Univ, Fac Med Charite, Inst Biochem, D-10117 Berlin, Germany
[2] Humboldt Univ, Fac Med Charite, Inst Pharmacol & Toxicol, D-10117 Berlin, Germany
[3] Max Planck Inst Infek Biol, Mol Biol Abt, D-10117 Berlin, Germany
关键词:
COP9;
signalosome;
26S proteasome;
19S regulator;
JNK;
curcumin;
D O I:
10.1023/A:1006991419464
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The human core COP9 signalosome consists of eight subunits which have been identified, cloned and sequenced. The components of COP9 signalosome possess homologies with eight non-ATPase regulatory subunits of the 26S proteasome. These polypeptides of the 19S regulator form a reversibly binding subcomplex called the 'lid'. We isolated the 'lid' from human red blood cells and compared it with the COP9 signalosome complex. In addition to the non-ATPase regulatory polypeptides, we found a high molecular mass ATPase copurifying with the human 'lid'. The COP9 signalosome-associated kinase activity is either not at all or only weakly affected by common kinase inhibitors such as 1-(5-Isoquinolinesulfonyl)-2-methyl- piperazine (H7), 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) or Wortmannin. Curcumin, a tumor suppressor and effector of AP-1 activation, is a potent inhibitor of the COP9 signalosome kinase activity with a Ki of about 10 mu M. Since curcumin is known as an inhibitor of the c-Jun N-terminal kinase (JNK) signaling pathway acting upstream of the MAP kinase kinase kinase level, one site of action of the COP9 signalosome might be proximal to regulators on that level.
引用
收藏
页码:29 / 34
页数:6
相关论文